Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.

86
Strong Buy
  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100001R58
CNY
25.17
0.09 (0.36%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Operating Income
1,058.00
922.00
845.00
892.00
804.00
634.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
1,058.00
922.00
845.00
892.00
804.00
634.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
Operating Expenses
1.00
1.00
1.00
0.00
0.00
0.00
General and Administration Expenses
453.00
413.00
366.00
350.00
326.00
256.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
647.00
600.00
536.00
508.00
457.00
353.00
Operating Profit (PBDIT) excl Other Income
411.00
321.00
308.00
384.00
347.00
280.00
Other Income
33.00
51.00
47.00
66.00
49.00
40.00
Operating Profit (PBDIT)
489.00
420.00
392.00
433.00
422.00
336.00
Interest
1.00
1.00
1.00
0.00
0.00
0.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
57.00
53.00
39.00
28.00
27.00
16.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
433.00
366.00
350.00
403.00
394.00
322.00
Provision for Tax
64.00
60.00
50.00
63.00
66.00
52.00
Profit After Tax
380.00
317.00
310.00
348.00
337.00
278.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
0.73
0.61
0.59
0.67
0.65
0.53
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is 14.81% vs 9.10% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 27.75% vs 4.35% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is -20.81% vs -9.94% in Dec 2024

stock-summary

Profit After Tax

YoY Growth in year ended Dec 2025 is 19.86% vs 2.46% in Dec 2024

Compare Profit and Loss Results of Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
No of Months
12
12
Operating Income
1,058.00
0
1,058.00
0%
Less :Inter divisional transfers
0.00
0
0.00
0%
Less: Excise
0.00
0
0.00
0%
Net Sales
1,058.00
0
1,058.00
0%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0
0.00
0%
Raw Materials Consumed
0.00
0
0.00
0%
Power & Fuel Cost
0.00
0
0.00
0%
Employee Cost
0.00
0
0.00
0%
Operating Expenses
1.00
0
1.00
0%
General and Administration Expenses
453.00
0
453.00
0%
Selling and Distribution Expenses
0.00
0
0.00
0%
Cost of Software developments
0.00
0
0.00
0%
Miscellaneous Expenses
0.00
0
0.00
0%
Expenses Capitalised
0.00
0
0.00
0%
Total Expenditure
647.00
0
647.00
0%
Operating Profit (PBDIT) excl Other Income
411.00
0.00
411.00
0%
Other Income
33.00
0
33.00
0%
Operating Profit (PBDIT)
489.00
0
489.00
0%
Interest
1.00
0
1.00
0%
Profit before Depriciation and Tax
0.00
0
0.00
0%
Depreciation
57.00
0
57.00
0%
Profit Before Taxation & Exceptional Items
0.00
0
0.00
0%
Exceptional Income / Expenses
0.00
0
0.00
0%
Profit Before Tax
433.00
0
433.00
0%
Provision for Tax
64.00
0
64.00
0%
Profit After Tax
380.00
0
380.00
0%
Extraordinary Items
0.00
0
0.00
0%
Adj to Profit After Tax
0.00
0
0.00
0%
Profit Balance B/F
0.00
0
0.00
0%
Profit Available for appropriations
0.00
0
0.00
0%
Appropriations
0.00
0
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
0.7276
0
0.73
0%
Profit And Loss - Net Sales
Net Sales 1,058.84 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 14.81% vs 9.10% in Dec 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 411.29 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 27.75% vs 4.35% in Dec 2024

Profit And Loss - Interest
Interest 1.05 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -20.81% vs -9.94% in Dec 2024

Profit And Loss - Profit After Tax
Profit After Tax 380.94 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 19.86% vs 2.46% in Dec 2024